Literature DB >> 10920171

Pioneers in the scientific study of neonatal jaundice and kernicterus.

T W Hansen1.   

Abstract

Neonatal jaundice must have been noticed by caregivers through the centuries, but the scientific description and study of this phenomenon seem to have started in the last half of the 18th century. In 1785 Jean Baptiste Thimotée Baumes was awarded a prize from the University of Paris for his work describing the clinical course in 10 jaundiced infants. The work by Jaques Hervieux, which he defended for his doctor of medicine degree in 1847, was, in many respects, a landmark. He had autopsied 44 jaundiced infants and apparently had clinical observations on many others. His descriptions of pathoanatomical findings were very detailed and systematic. A number of his clinical observations are still thought to be accurate today, such as the essentially benign nature of neonatal jaundice in most cases, the appearance of neonatal jaundice during the first 2 to 4 days of life as well as its disappearance within 1 to 2 weeks, and the cephalocaudal progression of jaundice. He described jaundice of the brain in 31 of his 44 autopsied cases, with variable intensity of staining. Johannes Orth was an assistant to the famous Virchow in Berlin, when in 1875 he published the results of an autopsy of a jaundiced term infant. The brain was notable for an intense yellow staining of the basal ganglia, the wall of the third ventricle, the hippocampus, and the central parts of the cerebellum. While the contribution of Orth was limited to this single case report, in 1903 Christian Schmorl presented the results of his autopsies of 120 jaundiced infants to the German Society for Pathology. All of these infants' brains were jaundiced, but only 6 cases demonstrated a staining phenomenon similar to that previously described by Orth. Schmorl coined the term kernicterus (jaundice of the basal ganglia) for this staining pattern. Although the following century of scientific study has added an enormous amount of information about the epidemiology and pathophysiology of neonatal jaundice and kernicterus, the contributions of Hervieux, Orth, and Schmorl will undoubtedly continue to be seen as historical landmarks in our quest for understanding of these phenomena.

Entities:  

Mesh:

Year:  2000        PMID: 10920171     DOI: 10.1542/peds.106.2.e15

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin.

Authors:  Andreia Barateiro; Ana Rita Vaz; Sandra Leitão Silva; Adelaide Fernandes; Dora Brites
Journal:  Neuromolecular Med       Date:  2012-06-17       Impact factor: 3.843

2.  Cross-talk between neurons and astrocytes in response to bilirubin: early beneficial effects.

Authors:  Ana Sofia Falcão; Rui F M Silva; Ana Rita Vaz; Sandra Leitão Silva; Adelaide Fernandes; Dora Brites
Journal:  Neurochem Res       Date:  2013-01-03       Impact factor: 3.996

3.  Rat cerebellar slice cultures exposed to bilirubin evidence reactive gliosis, excitotoxicity and impaired myelinogenesis that is prevented by AMPA and TNF-α inhibitors.

Authors:  Andreia Barateiro; Helena Sofia Domingues; Adelaide Fernandes; João Bettencourt Relvas; Dora Brites
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

4.  Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination.

Authors:  Andreia Barateiro; Veronique E Miron; Sofia D Santos; João B Relvas; Adelaide Fernandes; Charles Ffrench-Constant; Dora Brites
Journal:  Mol Neurobiol       Date:  2012-10-21       Impact factor: 5.590

Review 5.  Screening methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments.

Authors:  Christian V Hulzebos; Libor Vitek; Carlos D Coda Zabetta; Aleš Dvořák; Paul Schenk; Eline A E van der Hagen; Christa Cobbaert; Claudio Tiribelli
Journal:  Pediatr Res       Date:  2021-05-03       Impact factor: 3.756

6.  Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.

Authors:  Silvia Gazzin; Nathalie Strazielle; Claudio Tiribelli; Jean-François Ghersi-Egea
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

7.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

Review 8.  NEW INSIGHTS INTO THE PRESENCE OF BILIRUBIN IN A PLANT SPECIES STRELITZIA NICOLAI (STRELITZIACEAE).

Authors:  Depika Dwarka; Veneesha Thaver; Mickey Naidu; Himansu Baijnath
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

Review 9.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.